Steroid administration in CD1d−/− mice was associated with significant insulin resistance manifested by increased fasting serum glucose levels (Fig. 3a) and increased GTT (Fig. 3b), along with hypertriglyceridemia (Fig. 3c). Here, CD1D is linked to Insulin resistance.